Switzerland Tumor Ablation Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 96.65 Million |
 Market Size (Forecast Year) |
USD 269.95 Million |
 CAGR |
% |
| Major Markets Players |
瑞士肿瘤消融市场，按类型（化学消融、热消融及其他）、技术（射频、微波、冷冻消融、不可逆电穿孔 (IRE)、高强度聚焦超声 (HIFU)、激光、透视、超声、CT、MRI成像及其他）、治疗类型（开放手术、腹腔镜和经皮）、应用（肝、肾、骨、肺、子宫肌瘤、前列腺、乳腺及其他）、最终用户（医院、肿瘤中心及其他）、分销渠道（直销和第三方分销商）划分 - 行业趋势和预测到 2030 年。
瑞士肿瘤消融市场分析及规模
癌症发病率的上升是预测期内推动市场需求的主要因素。目前，正在进行大量研究，预计这将为不同制造商创造竞争优势，以开发新的、创新的和先进的消融药物，这些药物有望为肿瘤消融市场提供其他机会。主要市场参与者正在大量投资研发，以推出微创和创新的肿瘤消融解决方案，从而促进市场增长。
Data Bridge Market Research 分析了 2023-2030 年预测期内肿瘤消融市场的增长率。在上述预测期内，肿瘤消融市场的预期复合年增长率约为 13.70%。2022 年市场价值为 9665 万美元，到 2030 年将增长至 2.6995 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
瑞士肿瘤消融市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
类型（化学消融、热消融等）、技术（射频、微波、冷冻消融、不可逆电穿孔 (IRE)、高强度聚焦超声 (HIFU)、激光、透视、超声、CT、MRI 成像等）、治疗类型（开放手术、腹腔镜和经皮）、应用（肝、肾、骨、肺、子宫肌瘤、前列腺、乳腺等）、最终用户（医院、肿瘤中心等）、分销渠道（直销和第三方分销商） |
|
涵盖的市场参与者 |
AngioDynamics（美国）、Medtronic（爱尔兰）、Boston Scientific Corporation（美国）、BIOTRONIK SE & Co KG（德国）、EDAP TMS（法国）、HealthTronics, Inc.（美国）、Misonix（美国）、Medical Devices Business Services, Inc.（美国）、Erbe Elektromedizin GmbH（德国）、MERMAID MEDICAL A/S（丹麦）、BTG International Ltd（英国）、BVM Medical Limited（英国）、COMSOL INC.（瑞典）、Cortex Technology（丹麦）、CooperSurgical, Inc.（美国）、AtriCure, Inc（美国）、Abbott（美国）、Integra LifeSciences（美国）、Smith+Nephew（英国）、CONMED Corporation（美国） |
|
市场机会 |
|
市场定义
肿瘤消融是一种微创治疗，用于彻底摧毁或灭活癌细胞和肿瘤。肿瘤消融有几个优点，因为它使恢复变得容易和快速；它还为那些犹豫是否接受手术的患者提供了缓解。它还确保精确地摧毁肿瘤细胞，而不会真正损害未感染的细胞。
瑞士肿瘤消融市场动态
驱动程序
- 增加合作与合并
有几家市场参与者正在建立多项合作伙伴关系和协议，这些都有助于促进市场的增长。市场参与者采取了许多战略举措，如合作、合并、产品发布和收购，以巩固其在市场中的地位。例如，Auris Health 于 2018 年宣布与 Ethicon 合作开发机器人辅助支气管镜肿瘤消融系统。此外，全球最大的医疗技术公司 BD 宣布已于 2021 年收购 Venclose。这是一家医疗技术公司，其治疗慢性静脉功能不全 (CVI) 的解决方案，例如射频 (RF) 消融技术，其导管可以减轻术后疼痛。因此，这一因素促进了市场增长。
机会
- 组织机构监管批准不断增加
越来越多的监管机构批准技术先进的消融设备，推动了市场增长。例如，医疗技术全球领导者美敦力宣布，DiamondTempTM 消融 (DTA) 系统已于 2021 年在欧洲获得 FDA 批准，该系统用于治疗对药物治疗无反应的复发性、症状性阵发性心房颤动 (AF) 患者。因此，这一因素推动了市场的增长。
- 手术消融需求不断增长
肝癌和乳腺癌发病率的增加以及这些特定器官的先进肿瘤消融技术的广泛缺乏是预计推动市场增长的主要因素。这些手术可最大程度减少疤痕、加快恢复速度并提高安全性。除此之外，患者舒适度、快速手术时间和成本效益等其他因素预计会进一步增加该细分市场的需求。因此，这一因素促进了市场的增长。
限制/挑战
- 手术费用高昂
The increasing cost of surgeries such as open surgery, laparoscopic and percutaneous lead to the hindrance in the market growth. Many developing countries cannot upgrade these surgeries into the hospitals as it is quite costly and the treatment process gets slower. Thus, this factor hinders the market growth.
This tumor ablation market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tumor ablation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Switzerland Tumor Ablation Market Scope
The tumor ablation market is segmented on the basis of type, types of treatment, technology, application, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Chemical Ablation
- Thermal Ablation
- Others
Technology
- Radiofrequency
- Microwave
- Cryoablation
- Irreversible Electroporation (IRE)
- High Intensity Focused Ultrasound (HIFU)
- Laser
- Fluoroscopy
- Ultrasound
- CT
- MRI Imaging
- Others
Types of Treatment
- Open Surgery
- Laparoscopic
- Percutaneous
Application
- Liver
- Kidney
- Bone
- Lung
- Uterine Fibroid
- Prostate
- Breast
- Others
End User
- Hospitals
- Oncology Center
- Others
Distribution Channel
- Direct Sales
- Third Party Distributors
Competitive Landscape and Switzerland Tumor Ablation Market Share Analysis
The tumor ablation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Switzerland presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tumor ablation market.
Key players operating in the tumor ablation market include:
- Medtronic (Ireland)
- AngioDynamics (U.S.)
- Boston Scientific Corporation (U.S.)
- BIOTRONIK SE & Co KG (Germany)
- EDAP TMS (France)
- HealthTronics, Inc. (U.S.)
- Misonix (U.S.)
- Medical Devices Business Services, Inc. (U.S.)
- Erbe Elektromedizin GmbH (Germany)
- MERMAID MEDICAL A/S (Denmark)
- BTG International Ltd (U.K.)
- BVM Medical Limited (U.K.)
- COMSOL INC. (Sweden)
- Cortex Technology (Denmark)
- CooperSurgical, Inc. (U.S.)
- AtriCure, Inc (U.S.)
- Abbott (U.S.)
- Integra LifeSciences (U.S.)
- Smith+Nephew (U.K.)
- CONMED Corporation (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
